KYLK01
New molecular entity (NME), a small molecule under 500 Da.
What it does
New molecular entity (NME), a small molecule under 500 Da.
- Iron deficiency anemia treatment
- Organometallic drug development
- Transdermal drug delivery
- Category
- Drug discovery and biotech
- Built for
- Healthcare and life sciences
- Public API
- Not offered
Not yet disclosed: deployment options, platforms, languages and support channels.
Pricing
Pricing isn't published
Keylika doesn't list prices publicly. Ask them for a quote.
Security and compliance
No security details published yet
Keylika hasn't published certifications or security practices for KYLK01 that we could find. Ask their team for audit reports.
Reviews
No reviews yet
Reviews come from people who use KYLK01 at work. Share how your team uses it to help other buyers decide.
Alternatives
ITO™ Platform
by 1910
Cloud-based end-to-end platform integrating massive multimodal data, frontier AI models, and high-throughput lab automation to deliver small and large molecule drug candidates f...
AI Agents
by Enjamb Labs
Agentic orchestration that coordinates specialized agents across evidence, trial design, statistical programming, and regulatory writing inside one auditable workspace.
Integrations
by Invert
Pre-built connectivity to every instrument, historian, ELN/LIMS, and enterprise data store that matters in bioprocess.
Numerion Labs Drug Discovery Platform
by Numerion Labs
AI-driven drug-hunting superplatform that uses a universal chemistry foundation model (COSMOS), a hyper-scalable enumerator (APEX), and expert optimization algorithms (EXPO) to...
Scientific evidence synthesis service delivering structured evidence packages for target, indication, biomarker, and trial design decisions on named drug assets.
Precision medicine
by Parallel Bio
Maps of human biology for personalized insights and patient stratification in ways never previously possible.
Is this your product?
Claim it to keep details accurate and submit evidence for the next ranking review.
Claim KYLK01